Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y, Zhang Y
Accessing timely medical advice is crucial when managing side effects
DPP-4 inhibitors increase the endogenous GLP-1 concentrations ~2-3-fold, GLP-1 receptor agonists lead to 8-10-fold concentrations
A recent meta-analysis found GLP-1 drugs lowered the risk of major kidney complications, including in those who had existing heart disease but not diabetes
Its what kind of caregiver you are going to be
Correlation between intestinal flora and GLP-1 receptor agonist dulaglutide in type 2 diabetes mellitus treatmentA preliminary longitudinal study